KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Debt Ratio (2016 - 2025)

Historic Debt Ratio for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.05.

  • West Pharmaceutical Services' Debt Ratio fell 1044.59% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year decrease of 1044.59%. This contributed to the annual value of 0.06 for FY2024, which is 19251.17% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Debt Ratio of 0.05 as of Q3 2025, which was down 1044.59% from 0.05 recorded in Q2 2025.
  • West Pharmaceutical Services' 5-year Debt Ratio high stood at 0.09 for Q1 2021, and its period low was 0.02 during Q4 2023.
  • Its 5-year average for Debt Ratio is 0.06, with a median of 0.06 in 2025.
  • As far as peak fluctuations go, West Pharmaceutical Services' Debt Ratio crashed by 6673.61% in 2023, and later surged by 19251.17% in 2024.
  • West Pharmaceutical Services' Debt Ratio (Quarter) stood at 0.08 in 2021, then dropped by 25.14% to 0.06 in 2022, then tumbled by 66.74% to 0.02 in 2023, then soared by 192.51% to 0.06 in 2024, then fell by 11.22% to 0.05 in 2025.
  • Its last three reported values are 0.05 in Q3 2025, 0.05 for Q2 2025, and 0.06 during Q1 2025.